Averix Bio
Pharmaceutical Companies
Why pick this one
Averix Bio manufactures API CBD isolate under 21 CFR Parts 210/211 and ICH Q7 compliance, with FDA Drug Master File #MF036798.
Best for
- Pharmaceutical manufacturers sourcing API CBD isolate
- Cosmetic, nutraceutical, food, beverage, and veterinary product formulators
- Customers requiring USA-grown hemp ingredients
- Customers needing lot-level third-party testing and online COA access
- Businesses seeking THC-free CBD isolate or low-THC cannabinoid distillates
Specialties
- 99%+ API CBD isolate
- 99%+ CBG isolate
- full-spectrum CBD distillate
- broad-spectrum CBD distillate
- crystal-resistant CBD distillate
- water-dispersible CBD powder
Certifications
- 21 CFR Part 210/211 cGMP compliance
- ICH Q7 compliance
- EU GMP practices
- FDA Drug Master File #MF036798
What makes them different
- Vertically integrated seed-to-shelf production model
- 200,000-square-foot manufacturing facility on a 36-plus-acre North Carolina campus
- On-site analytical laboratory plus independent third-party testing for each production lot
- Client portal access to third-party Certificates of Analysis
- Ingredients derived from locally grown USA industrial hemp
- Serves
- Wilson
Distilled from this business's own website.
Contact & Location
- Address
- 3040 Black Creek Rd S, Wilson, NC 27893-9526
- Phone
- 12522200887
- Website
- https://averixbio.com
Services
- pharmaceutical-grade cannabinoid ingredient manufacturing
- hemp extraction and refinement
- on-site analytical testing
- third-party production-lot testing
- cannabinoid ingredient distribution